Shuwen Yang Dongmei Ji Fen Xue Tongzhen Chen Yu Wang Qinhai Ji
10.1002/cnr2.1770
Cancer Rep (Hoboken)
2023 Jan;6(1):e1770.
anaplastic thyroid cancer camrelizumab famitinib radiation therapy surgery
CC BY
https://pubmed.ncbi.nlm.nih.gov/36535914/
Thyroid Carcinoma, Anaplastic / diagnosis Thyroid Carcinoma, Anaplastic / drug therapy Thyroid Carcinoma, Anaplastic / genetics Thyroid Neoplasms / drug therapy Thyroid Neoplasms / genetics Thyroid Neoplasms / surgery
Thyroid Carcinoma, Anaplastic / diagnosis Thyroid Carcinoma, Anaplastic / drug therapy Thyroid Carcinoma, Anaplastic / genetics Thyroid Neoplasms / drug therapy Thyroid Neoplasms / genetics Thyroid Neoplasms / surgery Clinical Trial, Phase II Case Reports Humans Neoadjuvant Therapy Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins B-raf / genetics Proto-Oncogene Proteins B-raf / therapeutic use camrelizumab famitinib Proto-Oncogene Proteins B-raf Protein Kinase Inhibitors
PMC9875607
36535914
Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma
2023